These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9135403)

  • 1. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.
    Leonardi A; Borghesan F; Avarello A; Plebani M; Secchi AG
    Br J Ophthalmol; 1997 Jan; 81(1):23-6. PubMed ID: 9135403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis.
    Akman A; Irkeç M; Orhan M
    Eye (Lond); 1998; 12 ( Pt 2)():291-5. PubMed ID: 9683957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis.
    Leonardi A; Borghesan F; Faggian D; Secchi A; Plebani M
    Allergy; 1995 Jul; 50(7):610-3. PubMed ID: 8588697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tear and serum eosinophil cationic protein levels in seasonal allergic conjunctivitis.
    Acar N; Toker E; Kazokoğlu H
    Eur J Ophthalmol; 2003 Oct; 13(8):671-5. PubMed ID: 14620169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lodoxamide in vernal keratoconjunctivitis.
    Lee S; Allard TR
    Ann Pharmacother; 1996 May; 30(5):535-7. PubMed ID: 8740338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.
    Avunduk AM; Avunduk MC; Kapicioglu Z; Akyol N; Tavli L
    Ophthalmology; 2000 Jul; 107(7):1333-7. PubMed ID: 10890862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil cationic protein in tears in allergic conjunctivitis.
    Montan PG; van Hage-Hamsten M
    Br J Ophthalmol; 1996 Jun; 80(6):556-60. PubMed ID: 8759270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis.
    Oguz H; Bitiren M; Aslan OS; Ozardali I
    Acta Med Okayama; 1999 Jun; 53(3):123-6. PubMed ID: 10410789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis.
    Caldwell DR; Verin P; Hartwich-Young R; Meyer SM; Drake MM
    Am J Ophthalmol; 1992 Jun; 113(6):632-7. PubMed ID: 1598953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic rhinitis in children: effects of flunisolide and disodium cromoglycate on nasal eosinophil cationic protein.
    Sensi LG; Seri A; Siracusa A; Pertici L; Marcucci F
    Clin Exp Allergy; 1997 Mar; 27(3):270-6. PubMed ID: 9088653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tear tryptase in vernal keratoconjunctivitis.
    Tabbara KF
    Arch Ophthalmol; 2001 Mar; 119(3):338-42. PubMed ID: 11231766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of eosinophil cationic protein (ECP) and histamine in vernal keratoconjunctivitis.
    Secchi A; Leonardi A; Abelson M
    Ocul Immunol Inflamm; 1995; 3(1):23-8. PubMed ID: 22827228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.
    Verin P; Allewaert R; Joyaux JC; Piozzi E; Koliopoulos J; Bloch-Michel E;
    Eur J Ophthalmol; 2001; 11(2):120-5. PubMed ID: 11456011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activated eosinophils in vernal keratoconjunctivitis].
    Saiga T; Shimizu Y
    Nihon Rinsho; 1993 Mar; 51(3):816-9. PubMed ID: 8492463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.
    Leonardi A; Borghesan F; Faggian D; Depaoli M; Secchi AG; Plebani M
    Am J Ophthalmol; 2000 Feb; 129(2):151-8. PubMed ID: 10682966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study.
    Fahy GT; Easty DL; Collum LM; Benedict-Smith A; Hillery M; Parsons DG
    Eur J Ophthalmol; 1992; 2(3):144-9. PubMed ID: 1450659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: differences between tarsal and limbal forms.
    Pucci N; Novembre E; Lombardi E; Cianferoni A; Bernardini R; Massai C; Caputo R; Campa L; Vierucci A
    Clin Exp Allergy; 2003 Mar; 33(3):325-30. PubMed ID: 12614446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Abatangelo G; Plebani M; Secchi AG
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3052-8. PubMed ID: 12824251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis.
    Oh JW; Shin JC; Jang SJ; Lee HB
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):579-85. PubMed ID: 10400487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.
    Bonini S; Schiavone M; Bonini S; Magrini L; Lischetti P; Lambiase A; Bucci MG
    Ophthalmology; 1997 May; 104(5):849-53. PubMed ID: 9160033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.